Eurointervention

Article	Citations
TAVR under 70: is age just a number?	234
International variation in modality and outcomes of left main revascularisation: does it really matter?	128
Double-tap to treat paravalvular leak in high-risk annuli	106
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity	93
In search of the origin of the acronym TAVI	83
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis	77
Transcatheter left ventriculoplasty	77
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry	69
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s	63
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement	60
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis	60
Recanalisation of coronary chronic total occlusions	57
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study	52
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure	50
Defer-based non-stenting: a promising approach for STEMI	49
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection	48
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve	47
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study	46
Hybrid coronary revascularisation: the best or the worst of both worlds?	45
The “road travelled”: reflections on the transformation of information exchange in a digital age	42
   Atrial fibrillation and acute coronary syndrome 	41
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document	41
One-month DAPT after acute coronary syndrome: too short or not too short?	41
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarc	40
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation	40

Redo transcatheter mitral valve replacement in mitral annular calcification	39
A novel robotic radiation shielding device for interventional cardiology procedures	37
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes	36
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement	33
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial	33
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial	33
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons	33
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD	33
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study	32
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis	30
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation	30
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the ra	29
A nationwide analysis of reperfusion therapies for pulmonary embolism in older patients with frailty	29
Oesophageal and gastric injuries caused by transoesophageal probe manipulation in patients undergoing transcatheter edge-to-edge repair for tricuspid regurgitation	29
Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study	28
A novel three-dimensional imaging approach to evaluate coronary access before transcatheter aortic valve-in-valve implantation	28
Antithrombotic therapy for transcatheter structural heart intervention	28
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry	28
Percutaneous versus surgical transaxillary access for transcatheter aortic valve replacement: a propensity-matched analysis of the US experience	27
Cerebral embolic protection during transcatheter heart interventions	26
Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry	25
Management of cardiogenic shock	25
Shifting focus in bifurcations.	24
ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation	24
Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification	24
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial	24
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons	23
SYNTAXES, biomarkers and survival in complex coronary artery disease: the intervention of secondary prevention	23
Optical coherence tomography to visualise the endothelialisation of left atrial appendage occluders	23
Procedural and early outcomes of transcatheter edge-to-edge mitral valve repair in very elderly patients	22
Prevention of left ventricular outflow tract obstruction in transapical mitral valve replacement: the MitraCut procedure	22
UNICA − a novel single-stent, double-valve, heterotopic, cross-caval approach for severe tricuspid insufficiency 	21
New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation	21
Is transcatheter aortic valve implantation safe in patients with left ventricular outflow tract calcification?	21
Determinants of adverse outcomes following patent foramen ovale closure in elderly patients	21
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons	20
Supporting evidence for ST-segment elevation myocardial infarction from optical coherence tomography	20
Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome	20
Robotics, imaging, and artificial intelligence in the catheterisation laboratory	20
The ongoing conundrum of the best care for patients presenting with non-ST-segment elevation acute coronary syndrome	20
Predictors and clinical impact of worsening left ventricular ejection fraction after mitral transcatheter edge-to-edge repair	19
Targeting inflammation in atherosclerosis: overview, strategy and directions	19
Near-infrared spectroscopy to predict plaque progression in plaque-free artery regions	19
Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias	19
The patent foramen ovale does not spontaneously close in patients aged 60	19
Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis	18
SAPIEN 3 Ultra: better sealing, reduced paravalvular leak and a move in the right direction?	18
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation	18
Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis	18
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?	18

Stent underexpansion in the CRUNCH registry: worth cracking?	18
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?	17
Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation	17
Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair	17
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry	17
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis	17
Direct oral anticoagulants for ventricular thrombus resolution: pilot trials show reassuring efficacy and safety compared to warfarin	17
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI	17
PCR London Valves - in person or online - an invaluable opportunity for exchange dedicated to advancing the treatment of valvular heart disease	17
Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry	17
EuroIntervention: the 200th issue	15
We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons	15
Combined functional and anatomical assessment of coronary stenosis by coronary CT angiography	15
Transcatheter aortic valve implantation in degenerated surgical aortic valves	15
Letter: Caffeine and fractional flow reserve overestimation: a word of caution	15
Severely calcified coronary stenoses: a war or a battle?	15
Reply: Spontaneous coronary artery dissection in France	15
Device-related thrombus following left atrial appendage occlusion	14
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials	14
Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the FAST II study	13
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interv	13
Skating on thin ice: searching for vulnerable plaques	13
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies	13
One-step anatomic and function testing by cardiac CT versus second-line functional testing in symptomatic patients with coronary artery stenosis: head-to-head comparison of CT-derived fractional flow	12
Changes in absolute coronary flow and microvascular resistance during exercise in patients with ANOCA	12
Transcatheter closure of atrial septal defect and patent foramen ovale with Carag bioresorbable septal occluder: first-in-man experience with 24-month follow-up	12
Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation	12
Transcatheter interventions for heart failure	11
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial	11
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study	11
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary	11
Percutaneous Valvular and Structural Heart Disease Interventions.2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with	11
Paravalvular regurgitation after transcatheter aortic valve replacement in intermediate-risk patients: a pooled PARTNER 2 study	11
Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet Observational Post-Market Study	11
A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study	11
Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)	11
Coronary sinus reducer therapy for refractory angina: is it ready for prime time?	11
My stroke story	10
First experience of left atrial appendage occlusion using a 3D mini transoesophageal echocardiographic probe with conscious sedation	10
Coronary access after transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis	10
Understanding the past, getting prepared for the future. (Going from in vivo to in vitro to in silico)	9
Impact of mitral regurgitation aetiology on the outcomes of transcatheter aortic valve implantation	9
Letter: When is the optimal time point for detecting malapposition in coronary bifurcation trials?	9
Temporal patterns, characteristics, and predictors of clinical outcomes in patients undergoing percutaneous coronary intervention for stent thrombosis	9
Controlled antegrade and retrograde subintimal tracking (CART) for recanalisation of chronic total occlusions	9
Commissural alignment with the novel Hydra transcatheter heart valve during aortic valve replacement	9
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial	9
Pulmonary artery denervation – the suspense continues?	8
Changes in post-PCI optimisation strategies with post-procedural FFR followed by IVUS	8
Timing of bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity	8
“Lotus root”: a novel optical coherence tomography imaging pattern in spontaneous coronary artery dissection	8
Coronary artery cannulation after transcatheter aortic valve implantation	8
Repeat transcatheter aortic valve implantation and implications for transcatheter heart valve performance: insights from bench testing	8
Timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome: long-term clinical outcomes from the nationwide SWEDEHEART registry	8
Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial	7
Safety and efficiency of percutaneous coronary intervention using a standardised optical coherence tomography workflow	7
Radial wall strain: a novel angiographic measure of plaque composition and vulnerability	7
Breaking down the barriers in the management of INOCA: how can we do better in the diagnosis of coronary vasomotor disorders?	7
A deep learning algorithm for detecting acute myocardial infarction	7
Transcatheter tricuspid interventions are performed too late: pros and cons	7
Thirty years of transradial coronary interventions	7
Robotic-assisted percutaneous coronary intervention: the future or the past?	6
Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trial	6
Outcomes by sex in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial	6
Transseptal puncture: procedural guidance, challenging situations and management of complications	6
Microaxial flow pump for high-risk PCI: are we ready for the prime time?	6
Echocardiographic guidance in transcatheter structural cardiac interventions	6
TAVI at 20: how a crazy idea led to a clinical revolution	6
Histological examination of renal nerve distribution, density, and function in humans	6
Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and	6
Durability of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: the last missing piece?	5
Low-flow, low-gradient aortic stenosis: an understanding is still a long way off	5
The 17th expert consensus document of the European Bifurcation Club – techniques to preserve access to the side branch during stepwise provisional stenting	5
Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation	5
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike	5
Treatment of coronary bifurcation lesions, part II: implanting two stents. The 16th expert consensus document of the European Bifurcation Club	5
Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial	5
Embolisation of a prosthetic mitral valve fragment during valve-in-valve transcatheter mitral valve implantation	5
New-onset or newly detected atrial fibrillation after transcatheter aortic valve implantation?	5
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial	5

Scores and algorithms in CTO PCI: “PROGRESS” or an exercise in futility?	5
Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry	4
Consider aspirin bridging for non-cardiac surgery in patients with coronary stents treated with oral anticoagulation monotherapy	4
A comparison of risk prediction models for patients with acute coronary syndromes	4
Cost-effectiveness of an FFR-guided strategy during STEMI – no rose without a thorn	4
Stop at the yellow light spot: in vivo detection of preclinical atherosclerosis	4
Treatment of patent foramen ovale	4
Reply: The time has come to use attitudinally appropriate terminology when describing cardiac anatomy	4
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial	4
Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial	4
Transcatheter aortic valve implantation of a novel system for severe pure native aortic regurgitation in a patient with an ascending aorta aneurysm	4
Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SOR	4
Electrosurgical laceration and stabilisation of three clip devices (ELASTA-Clip) to enable transcatheter mitral valve implantation	4
TAVI in asymptomatic patients with severe aortic stenosis: pros and cons	4
Outcomes of quantitative flow ratio-based percutaneous coronary intervention in an all-comers study	4
Proximal optimisation technique versus final kissing balloon inflation in coronary bifurcation lesions: the randomised, multicentre PROPOT trial	4
Letter: Composite endpoints in clinical trials - simplicity or perfection?	4
Balloon-expandable versus self-expanding stents in native coarctation of the aorta: three-year results of a randomised controlled trial 	3
Transcatheter tricuspid valve repair/replacement should be offered to all patients with severe tricuspid regurgitation: pros and cons	3
Low urine pH: a new marker for contrast-associated acute kidney injury?	3
A prospective, first-in-human use of the NeVa mechanical thrombectomy device for patients with acute coronary syndromes	3
Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study	3
Quantitative flow ratio versus fractional flow reserve for Heart Team decision-making in multivessel disease: the randomised, multicentre DECISION QFR trial	3
VA-ECMO in cardiogenic shock: is the road closed or open?	3
Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules	3
Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month D	3
Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicentre, observational, post-market surveillance study	3
Treatment of severe aortic valve regurgitation with the Trilogy TAVI system	3
Prognostic impact and clinical outcomes of coronary flow reserve and hyperaemic microvascular resistance	3
Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)	3
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial	3
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study	2
Transcatheter edge-to-edge repair of severe calcific mitral regurgitation facilitated by balloon lithotripsy	2
Economic evaluation of fractional flow reserve-guided versus angiography-guided multivessel revascularisation in ST-segment elevation myocardial infarction patients in the FLOWER-MI randomised trial	2
Reply: ORBITA-2 trial design and rationale: what causes angina after PCI?	2
Phasic flow patterns of right versus left coronary arteries in patients undergoing clinical physiological assessment	2
First-in-human description of a novel transcatheter tricuspid valve prosthesis to preserve the asymmetric shape of the right ventricle	2
Letter: ORBITA-2 trial design and rationale: what causes angina after PCI?	2
Women and coronary artery disease: not just underrepresented and underdiagnosed, but also undertreated!	2
A bench study of balloon-expandable valves for the treatment of self-expanding valve failure	2
Double LAmbre technique for percutaneous occlusion of very large left atrial appendages: a case series	2
Temporal trends in clinical outcomes after percutaneous coronary intervention: a systematic review of 66,327 patients from 25 all-comers trials	2
PCI of bystander coronary artery lesions should be performed before TAVI: pros and cons	2
Transcatheter aortic valve implantation with the Evolut platform for bicuspid aortic valve stenosis: the international, multicentre, prospective BIVOLUTX registry	2
A study of the novel SinoCrown system for transcatheter aortic valve implantation	2
Standardisation of techniques for bifurcation stenting optimisation: the journey continues	2
Comprehensive diagnosis in chronic coronary syndromes combining angiography and intracoronary testing: the AID-ANGIO study	2
Prevalence and patterns of in-stent neoatherosclerosis in lower extremity artery disease	2
In search of the “IDEAL” left main coronary stent and DAPT regimen	2
TAVI in moderate aortic stenosis and heart failure: pros and cons	2
Napkin ring formation in culotte stenting using current-generation drug-eluting stents in left main coronary artery bifurcation	2
                Late lumen enlargement after drug-coated balloo	2
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial	2
Long-term outcomes of catheter-based intervention for clinically significant paravalvular leak	2
Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification	2
Catheter directed therapies: an option for elderly frail patients with pulmonary embolism requiring reperfusion	2
Intravascular ultrasound guidance for lower extremity arterial and venous interventions	2
Mechanical thrombectomy for pulmonary embolism revisited: technological breakthrough or simple renovation?	2
Letter: Pretreatment with unfractioned heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?	2
Valve-in-valve TAVI: the new standard therapy for failing bioprosthetic valves?	2
Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged	2
Learning the lessons (again) of the challenges of conducting sham-controlled device trials in hypertension	2
New European insights on spontaneous coronary artery dissection (SCAD): are we any closer in our scientific exploration voyage?	2